Class Details

Drug Abuse History & Sedation Best Practices course flyer, November 13, 2026

Drug Abuse History & Sedation Best Practices 2 Hours of CE November 13, 2026 (Dentists only/Dinner Included!)

Evening CE + Dinner

Join the Washington Dental Anesthesia Academy on Friday, November 13, 2026, for 2 hours of CE on caring for patients with a history of drug abuse: how substance use changes your anesthesia and sedation plan, and how to control post-operative pain while avoiding or minimizing opioids, including suzetrigine (JOURNAVX), the first new class of non-opioid pain medicine in over 20 years.

✓ 2 CE hours in one evening

✓ Dinner at 5:30 PM, lecture 6:00–8:00 PM

✓ Guaranteed to make an impact to your practice!

19 in stock (can be backordered)

Course Summary

More of your patients have a history of drug use than their medical history shows, and it changes how you sedate them and how you manage their pain. This 2-hour evening course gives Washington dentists and their teams a practical plan for patients with a history of drug abuse, from the pre-op conversation to the post-op prescription.

The first hour covers how commonly misused substances affect anesthesia and sedation in the dental chair: what to ask, which red flags matter, and when to modify the plan, delay treatment, or refer. The second hour focuses on controlling post-operative pain while avoiding or minimizing opioids, using different drug classes and evidence-based multimodal approaches.

We will also cover what is new in acute pain management: suzetrigine (JOURNAVX), the first new class of non-opioid pain medicine approved in over 20 years, including how it works, which patients it fits, and the drug interactions to watch before adding it to your post-op pain plan.

Who Should Attend?

  • Dentists who perform extractions, implants, or other procedures where post-operative pain control matters
  • Dentists who provide nitrous oxide, minimal, moderate, IV, or deep sedation
  • Dentists who treat patients with a history of substance use or patients in recovery

Course Highlights

  • 2 CE hours in a single evening
  • Taught by two nurse anesthesiologists (CRNAs) who have provided anesthesia in more than 250 Washington dental offices
  • Dinner included before the lecture
  • Small group: limited to 30 seats
  • Up to date: current ADA guidance on acute dental pain and the newest non-opioid option, suzetrigine (JOURNAVX)
  • Practical takeaways: screening questions and a post-op pain plan you can use the next day

Learning Objectives

By the end of this course, participants will be able to:

  1. Describe how commonly misused substances, including opioids, stimulants, cannabis, alcohol, and benzodiazepines, affect sedation, local anesthesia, and airway risk in the dental office.
  2. Identify screening questions and medical-history red flags that suggest active substance use, and recognize when to modify the anesthesia plan, delay treatment, or refer.
  3. Plan safe anesthesia and pain control for patients in recovery who take buprenorphine, methadone, or naltrexone.
  4. Build an evidence-based, multimodal post-operative pain plan that avoids or minimizes opioids.
  5. Compare non-opioid drug classes for acute dental pain, including NSAIDs, acetaminophen, long-acting local anesthetics, and suzetrigine (JOURNAVX), along with their key interactions and contraindications.

Your Evening at a Glance

5:30 PM Check-in and dinner
6:00 – 7:00 PM Hour 1: Drug Abuse and How It Affects Anesthesia

  • How opioids, stimulants (methamphetamine, cocaine), cannabis, alcohol, and benzodiazepines change sedation, local anesthesia, and airway risk
  • Screening questions and medical-history red flags in the pre-op conversation
  • Patients in recovery: buprenorphine, methadone, and naltrexone
  • When to modify the plan, delay treatment, or refer
  • Real-world case examples
7:00 – 8:00 PM Hour 2: Post-Op Pain Control Without Relying on Opioids

  • Evidence-based multimodal plans: NSAID and acetaminophen combinations and long-acting local anesthetics
  • Different drug classes for post-operative pain and when to use each
  • What is new: suzetrigine (JOURNAVX), how it works, who it fits, and the drug interactions to watch
  • Prescribing for patients with a substance use history or in recovery
8:00 PM Adjourn

Event Details

Date Friday, November 13th, 2026
Time Dinner at 5:30 PM; lecture 6:00 – 8:00 PM
Location Office of Kevin M. Brown, DDS (Minimally Invasive Dental Aesthetics)
301 116th Ave SE, Suite 100, Bellevue, WA 98004
CE Credit 2 CE hours
Tuition $150 per person (dinner included)
Seats Limited to 30
Format In person: lecture and case discussion
Instructors Michael Mielniczek, CRNA and James Prince, CRNA

CE Credit and Sponsorship

This course provides 2 hours of live continuing education.

Dinner is provided with support from Vertex Pharmaceuticals. Course content is developed independently by the Washington Dental Anesthesia Academy, and medications are presented using balanced, evidence-based information.

Ready to Register?

Seats are limited to 30. Reserve your spot and join fellow Washington dentists for a practical, up-to-date evening on caring for patients with a history of drug abuse, with dinner included.

Questions? Call (978) 413-2215 or email wadentalanesthesia@gmail.com